Nifty

:

16992.55

Sensex

:

57720.37

47.50 (0.28%)
193.27 (0.34%)

Login

Nifty
Sensex

:
:

16992.55
57720.37

47.50 (0.28%)
193.27 (0.34%)

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

38/99

BSE: 524669 | NSE: HESTERBIO

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,430.30
47.93
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,627.67
0.59%
5.21

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.70
11.57
8.64

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.61
4.89
1.60

PAT CAGR (%)

10 Years
5 Years
3 Years

15.43
8.71
10.07

P:E (Median)

8 Years
5 Years
3 Years

40.88
47.88
52.49

P:BV (Average)

8 Years
5 Years
3 Years

7.21
7.48
7.28

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.60
24.41
26.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 70.77 54.00 31.06% 72.00 56.59 27.23% 50.53 58.50 -13.62% 50.25 63.16 -20.44%
Expenses 51.79 38.77 33.58% 56.22 39.46 42.47% 41.33 40.36 2.40% 40.20 42.54 -5.50%
EBITDA 18.99 15.23 24.69% 15.78 17.14 -7.93% 9.20 18.15 -49.31% 10.05 20.62 -51.26%
EBIDTM 26.83% 28.20% 21.92% 30.28% 18.20% 31.02% 20.01% 32.64%
Other Income 0.96 1.22 -21.31% 2.18 1.32 65.15% 1.23 1.03 19.42% 1.08 0.12 800.00%
Interest 3.14 0.37 748.65% 1.74 0.35 397.14% 1.27 0.37 243.24% 1.38 0.47 193.62%
Depreciation 2.44 2.33 4.72% 2.34 2.32 0.86% 2.39 2.30 3.91% 2.55 2.45 4.08%
PBT 14.38 13.75 4.58% 13.88 15.78 -12.04% 6.77 16.52 -59.02% 7.20 12.54 -42.58%
Tax 3.65 3.20 14.06% 3.53 4.01 -11.97% 1.76 4.28 -58.88% 2.26 3.68 -38.59%
PAT 10.73 10.56 1.61% 10.35 11.77 -12.06% 5.00 12.24 -59.15% 4.95 8.86 -44.13%
PATM 15.16% 19.55% 14.37% 20.80% 9.91% 20.92% 9.85% 14.03%
EPS 12.62 12.42 1.61% 12.17 13.85 -12.13% 5.89 14.40 -59.10% 5.82 10.42 -44.15%

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 74.94 55.69 34.57% 73.15 62.66 16.74% 50.70 60.19 -15.77% 56.47 64.17 -12.00%
Expenses 56.19 40.66 38.19% 60.41 45.10 33.95% 43.27 43.12 0.35% 46.14 44.40 3.92%
EBITDA 18.76 15.03 24.82% 12.74 17.56 -27.45% 7.43 17.07 -56.47% 10.33 19.78 -47.78%
EBIDTM 25.03% 26.99% 17.42% 28.02% 14.66% 28.36% 18.28% 30.82%
Other Income 4.39 2.78 57.91% 4.45 1.42 213.38% 3.12 2.35 32.77% 7.19 2.48 189.92%
Interest 3.89 0.96 305.21% 2.46 0.74 232.43% 1.60 0.86 86.05% 1.50 1.44 4.17%
Depreciation 5.24 5.17 1.35% 5.03 3.05 64.92% 5.06 3.23 56.66% 5.13 3.63 41.32%
PBT 14.02 11.68 20.03% 9.71 15.19 -36.08% 3.89 15.33 -74.62% 10.89 13.87 -21.49%
Tax 3.84 3.35 14.63% 3.67 4.06 -9.61% 1.90 4.31 -55.92% 2.30 3.77 -38.99%
PAT 10.18 8.33 22.21% 6.04 11.13 -45.73% 1.99 11.02 -81.94% 8.58 10.10 -15.05%
PATM 13.58% 14.96% 8.26% 17.76% 3.92% 18.31% 15.20% 15.74%
EPS 13.15 9.97 31.90% 8.16 12.49 -34.67% 4.66 14.68 -68.26% 9.08 11.39 -20.28%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 243.55 219.35 208.48 169.43 171.19 134.79 123.28 100.89 90.04 69.05 65.10 Net Sales Growth 4.87% 5.21% 23.05% -1.03% 27.00% 9.34% 22.19% 12.05% 30.40% 6.07% Cost Of Goods Sold 74.15 61.70 53.39 29.24 29.21 23.31 29.89 19.75 25.29 11.39 15.42 Gross Profit 169.40 157.65 155.08 140.19 141.97 111.47 93.39 81.14 64.75 57.65 49.68 GP Margin 69.56% 71.87% 74.39% 82.74% 82.93% 82.70% 75.75% 80.42% 71.91% 83.49% 76.31% Total Expenditure 189.54 160.74 136.48 116.70 103.42 85.19 82.21 67.50 63.87 43.72 42.70 Power & Fuel Cost - 8.74 6.93 7.29 7.08 5.84 5.31 5.81 4.70 4.40 3.30 % Of Sales - 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% 5.76% 5.22% 6.37% 5.07% Employee Cost - 39.12 33.45 37.16 26.74 22.29 18.32 15.44 12.24 9.84 9.06 % Of Sales - 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% 15.30% 13.59% 14.25% 13.92% Manufacturing Exp. - 12.02 10.79 11.31 10.95 9.24 6.97 7.85 4.94 5.28 4.15 % Of Sales - 5.48% 5.18% 6.68% 6.40% 6.86% 5.65% 7.78% 5.49% 7.65% 6.37% General & Admin Exp. - 14.79 13.24 16.34 11.77 12.92 11.35 10.23 8.65 7.22 6.09 % Of Sales - 6.74% 6.35% 9.64% 6.88% 9.59% 9.21% 10.14% 9.61% 10.46% 9.35% Selling & Distn. Exp. - 17.16 13.68 11.42 16.02 9.09 8.15 6.77 7.14 4.87 4.34 % Of Sales - 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% 6.71% 7.93% 7.05% 6.67% Miscellaneous Exp. - 7.21 5.00 3.95 1.65 2.50 2.22 1.64 0.90 0.71 4.34 % Of Sales - 3.29% 2.40% 2.33% 0.96% 1.85% 1.80% 1.63% 1.00% 1.03% 0.51% EBITDA 54.02 58.61 72.00 52.73 67.77 49.60 41.07 33.39 26.17 25.33 22.40 EBITDA Margin 22.18% 26.72% 34.54% 31.12% 39.59% 36.80% 33.31% 33.10% 29.06% 36.68% 34.41% Other Income 5.45 6.61 1.65 2.93 3.10 1.88 0.73 0.87 0.33 0.77 0.23 Interest 7.53 2.47 3.95 5.03 3.54 2.32 3.21 3.69 4.41 6.43 3.22 Depreciation 9.72 9.50 9.63 9.38 7.57 5.45 5.51 5.73 5.29 5.38 4.39 PBT 42.23 53.26 60.06 41.23 59.75 43.71 33.09 24.85 16.80 14.29 15.03 Tax 11.20 13.74 14.88 10.01 15.90 13.15 8.15 5.63 4.87 4.20 5.34 Tax Rate 26.52% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% 22.66% 25.04% 29.39% 35.53% PAT 31.03 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 10.09 9.69 PAT before Minority Interest 31.03 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 10.09 9.69 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.74% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% 19.05% 16.19% 14.61% 14.88% PAT Growth -28.55% -0.95% 27.80% -28.80% 43.49% 22.53% 29.76% 31.82% 44.50% 4.13% EPS 36.51 46.49 46.94 36.73 51.59 35.95 29.34 22.61 17.15 11.87 11.40

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 255.26 235.01 214.33 183.27 178.07 135.94 123.11 100.89 90.64 69.05 65.10 Net Sales Growth 5.17% 9.65% 16.95% 2.92% 30.99% 10.42% 22.02% 11.31% 31.27% 6.07% Cost Of Goods Sold 70.96 62.71 50.23 27.98 28.47 23.31 28.45 19.75 25.32 11.39 15.42 Gross Profit 184.30 172.29 164.11 155.29 149.60 112.63 94.65 81.14 65.32 57.65 49.68 GP Margin 72.20% 73.31% 76.57% 84.73% 84.01% 82.85% 76.88% 80.42% 72.07% 83.49% 76.31% Total Expenditure 206.01 175.02 145.67 127.87 110.03 88.68 82.09 67.50 65.90 44.60 43.21 Power & Fuel Cost - 10.28 7.57 8.13 7.83 6.37 5.59 5.81 4.77 4.40 3.30 % Of Sales - 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% 5.76% 5.26% 6.37% 5.07% Employee Cost - 45.33 38.92 40.65 28.93 23.24 18.32 15.44 12.32 9.84 9.06 % Of Sales - 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% 15.30% 13.59% 14.25% 13.92% Manufacturing Exp. - 13.36 11.60 11.98 11.34 9.45 7.06 7.85 5.25 5.28 4.15 % Of Sales - 5.68% 5.41% 6.54% 6.37% 6.95% 5.73% 7.78% 5.79% 7.65% 6.37% General & Admin Exp. - 19.49 15.29 13.47 13.72 13.81 11.47 10.23 8.90 7.23 6.09 % Of Sales - 8.29% 7.13% 7.35% 7.70% 10.16% 9.32% 10.14% 9.82% 10.47% 9.35% Selling & Distn. Exp. - 17.31 14.73 18.97 16.77 9.11 8.15 6.77 7.14 4.87 4.34 % Of Sales - 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% 6.71% 7.88% 7.05% 6.67% Miscellaneous Exp. - 6.53 7.34 6.69 2.98 3.40 3.05 1.64 2.20 1.58 4.34 % Of Sales - 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% 1.63% 2.43% 2.29% 1.29% EBITDA 49.26 59.99 68.66 55.40 68.04 47.26 41.02 33.39 24.74 24.45 21.89 EBITDA Margin 19.30% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% 33.10% 27.29% 35.41% 33.63% Other Income 19.15 13.74 4.68 6.37 7.21 2.55 0.42 0.88 0.34 0.79 0.20 Interest 9.45 4.06 6.60 7.37 6.63 4.04 3.50 3.72 4.83 6.46 3.26 Depreciation 20.46 16.58 13.31 13.07 11.76 9.66 7.00 5.75 5.92 5.41 4.43 PBT 38.51 53.08 53.42 41.33 56.86 36.12 30.93 24.81 14.33 13.37 14.41 Tax 11.71 14.02 15.40 10.32 16.16 13.05 8.15 5.63 4.82 4.20 5.34 Tax Rate 30.41% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% 22.69% 28.39% 31.41% 37.06% PAT 26.79 38.90 34.43 29.17 41.56 25.62 23.55 19.19 12.47 9.45 9.26 PAT before Minority Interest 25.29 39.06 34.70 31.00 40.69 23.07 22.79 19.18 12.17 9.16 9.07 Minority Interest -1.50 -0.16 -0.27 -1.83 0.87 2.55 0.76 0.01 0.30 0.29 0.19 PAT Margin 10.50% 16.55% 16.06% 15.92% 23.34% 18.85% 19.13% 19.02% 13.76% 13.69% 14.22% PAT Growth -33.98% 12.98% 18.03% -29.81% 62.22% 8.79% 22.72% 53.89% 31.96% 2.05% EPS 31.52 45.76 40.51 34.32 48.89 30.14 27.71 22.58 14.67 11.12 10.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 268.43 237.58 203.08 179.44 146.08 122.09 100.32 84.25 75.97 67.87 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 259.93 229.07 194.57 170.93 137.57 113.58 91.81 75.74 67.47 59.37 Non-Current Liabilities 81.17 9.79 15.89 21.51 21.98 22.36 21.05 21.29 11.13 10.43 Secured Loans 73.25 2.68 7.45 11.37 14.61 18.66 12.87 14.52 5.44 7.83 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 0.76 0.00 Long Term Provisions 1.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 74.84 34.65 58.22 39.30 42.43 33.99 37.45 34.87 41.71 36.39 Trade Payables 11.03 14.03 13.61 8.05 7.85 7.47 5.84 4.63 4.46 5.67 Other Current Liabilities 29.34 15.11 12.37 10.05 9.33 7.82 8.55 6.22 7.19 8.80 Short Term Borrowings 33.29 1.71 31.80 20.94 24.19 17.51 21.04 20.08 26.25 13.65 Short Term Provisions 1.18 3.81 0.44 0.26 1.06 1.18 2.02 3.95 3.80 8.27 Total Liabilities 424.44 282.02 277.19 240.25 210.49 178.44 158.82 140.41 128.81 114.69 Net Block 84.31 86.69 96.76 100.81 66.74 60.85 61.57 56.53 50.68 34.70 Gross Block 171.17 164.64 166.61 161.97 120.89 109.55 105.07 94.40 83.48 62.19 Accumulated Depreciation 86.86 77.95 69.85 61.02 54.15 48.70 43.50 37.87 32.81 27.49 Non Current Assets 257.97 142.41 154.01 140.84 121.36 103.63 91.64 87.65 75.52 66.44 Capital Work in Progress 81.91 3.72 0.87 0.42 30.47 21.29 10.47 14.27 13.15 24.05 Non Current Investment 64.69 43.88 40.67 28.22 14.48 8.60 8.67 8.88 3.63 2.78 Long Term Loans & Adv. 24.20 5.32 11.83 9.81 9.59 12.41 10.93 7.97 8.06 4.91 Other Non Current Assets 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 0.00 0.00 Current Assets 166.47 139.61 123.18 99.40 89.13 74.81 67.18 52.77 53.30 48.25 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 70.73 57.01 60.43 48.50 38.70 33.07 33.62 29.11 35.59 31.10 Sundry Debtors 56.92 45.55 44.76 32.67 31.94 26.71 26.24 17.76 14.06 15.04 Cash & Bank 1.98 1.24 5.19 2.49 11.95 11.48 5.26 4.38 1.06 1.08 Other Current Assets 36.84 6.30 0.96 2.79 6.54 3.56 2.07 1.51 2.59 1.02 Short Term Loans & Adv. 34.01 29.50 11.84 12.95 5.69 3.30 2.07 1.51 2.59 1.02 Net Current Assets 91.64 104.96 64.96 60.10 46.70 40.82 29.73 17.89 11.59 11.86 Total Assets 424.44 282.02 277.19 240.24 210.49 178.44 158.82 140.42 128.82 114.69

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 259.99 228.31 201.07 177.46 140.63 121.95 101.71 84.92 75.01 67.30 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 251.48 219.80 192.56 168.95 132.13 113.44 93.20 76.41 66.50 58.79 Non-Current Liabilities 197.87 113.72 96.64 69.64 44.41 48.32 41.28 37.66 20.46 16.31 Secured Loans 164.54 82.84 76.48 58.35 36.54 44.62 33.09 30.89 14.76 13.71 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 0.76 0.00 Long Term Provisions 1.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 96.90 61.37 83.46 48.66 54.63 38.01 38.20 35.01 45.47 38.89 Trade Payables 18.02 28.09 20.02 8.75 7.90 7.47 5.84 4.63 4.52 5.71 Other Current Liabilities 42.81 22.52 30.44 17.15 20.26 11.04 9.30 6.35 7.41 8.84 Short Term Borrowings 34.84 3.28 32.54 22.50 25.41 18.32 21.04 20.08 29.74 16.08 Short Term Provisions 1.22 7.48 0.46 0.26 1.07 1.18 2.02 3.95 3.80 8.27 Total Liabilities 562.17 411.05 386.59 299.46 244.04 212.88 185.84 160.46 142.22 123.70 Net Block 237.17 132.76 142.54 144.82 110.22 102.62 64.63 59.60 53.82 37.73 Gross Block 348.16 228.12 226.04 215.94 170.22 152.95 108.25 97.57 86.69 65.25 Accumulated Depreciation 110.99 95.36 83.50 70.98 60.00 50.33 43.62 37.97 32.87 27.52 Non Current Assets 367.40 249.54 227.29 157.80 145.59 132.91 111.63 100.45 85.12 73.90 Capital Work in Progress 81.91 109.17 74.15 7.05 31.81 21.29 36.46 32.60 20.55 28.89 Non Current Investment 21.24 0.00 0.00 0.00 0.00 0.00 0.07 0.28 0.28 0.28 Long Term Loans & Adv. 24.22 4.82 6.74 4.34 3.48 8.52 10.47 7.97 10.47 7.00 Other Non Current Assets 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 0.00 0.00 Current Assets 194.76 161.50 159.31 141.66 98.45 79.97 74.20 60.00 57.10 49.80 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 75.38 62.22 63.97 50.79 39.76 33.41 33.62 29.11 35.59 31.10 Sundry Debtors 55.28 49.21 58.44 32.87 32.29 26.53 26.24 17.76 14.06 15.04 Cash & Bank 25.20 21.27 23.53 41.05 13.39 11.48 5.28 6.58 4.85 2.63 Other Current Assets 38.90 2.56 5.18 5.63 13.01 8.54 9.05 6.55 2.60 1.03 Short Term Loans & Adv. 33.70 26.24 8.19 11.32 8.95 5.06 2.49 6.55 2.60 1.03 Net Current Assets 97.87 100.14 75.84 92.99 43.82 41.95 36.00 25.00 11.63 10.91 Total Assets 562.16 411.04 386.60 299.46 244.04 212.88 185.83 160.45 142.22 123.70

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 15.90 41.10 25.82 36.19 32.28 27.55 18.64 20.37 11.39 13.42 PBT 53.26 54.78 41.23 59.75 43.71 33.09 24.85 18.81 14.29 15.03 Adjustment 11.70 19.61 12.25 8.50 7.34 8.74 9.31 7.23 11.60 7.45 Changes in Working Capital -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 -9.54 -0.23 -4.63 -3.56 Cash after chg. in Working capital 32.34 54.59 37.17 51.78 41.67 34.61 24.62 25.82 21.26 18.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 -5.97 -5.45 -9.86 -5.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 -5.68 -12.02 -14.00 -17.52 Net Fixed Assets -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 -10.39 -20.32 Net Investments -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 -0.85 -0.28 Others -5.05 0.37 -3.79 0.07 0.08 -0.26 0.98 5.27 -2.76 3.08 Cash from Financing Activity 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 -11.92 -5.21 2.54 3.94 Net Cash Inflow / Outflow 0.28 -3.95 3.10 -8.80 -0.28 6.46 1.04 3.13 -0.06 -0.16 Opening Cash & Equivalents 1.24 5.19 2.09 10.89 11.17 4.71 3.92 0.69 0.75 0.90 Closing Cash & Equivalent 1.53 1.24 5.19 2.09 10.89 11.17 4.96 3.92 0.69 0.75

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 8.81 58.05 36.77 46.71 38.02 34.80 18.85 19.76 9.39 11.54 PBT 53.50 50.10 41.33 56.86 36.12 30.93 24.81 18.20 13.37 14.41 Adjustment 11.10 20.34 20.13 17.92 13.63 10.86 9.38 7.34 11.91 7.67 Changes in Working Capital -38.68 1.54 -13.75 -12.26 -2.31 0.11 -9.37 -0.33 -6.02 -5.04 Cash after chg. in Working capital 25.92 71.99 47.71 62.52 47.44 41.90 24.82 25.21 19.25 17.04 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 -5.97 -5.45 -9.86 -5.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 0.00 0.00 Cash From Investing Activity -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 -13.30 -21.21 -14.59 -22.55 Net Fixed Assets -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 -10.39 -20.32 Net Investments -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 -0.85 -0.28 Others -11.06 -34.28 -56.93 3.04 0.57 -14.96 -6.64 -3.92 -3.35 -1.95 Cash from Financing Activity 111.61 -18.22 18.74 2.65 -11.08 1.83 -6.68 6.76 7.38 9.90 Net Cash Inflow / Outflow 3.83 1.46 -18.96 27.63 1.12 6.45 -1.14 5.31 2.19 -1.12 Opening Cash & Equivalents 21.27 23.53 40.65 12.33 11.18 4.73 6.12 0.82 2.29 3.41 Closing Cash & Equivalent 24.75 21.27 23.53 40.65 12.33 11.18 4.99 6.12 4.48 2.29

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 315.54 279.28 238.72 210.93 171.72 143.52 117.93 101.13 89.31 79.79 ROA 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% 12.85% 10.82% 8.29% 9.38% ROE 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% 20.83% 18.00% 14.03% 15.15% ROCE 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% 21.79% 20.29% 20.38% 21.67% Fixed Asset Turnover 1.31 1.26 1.03 1.21 1.17 1.17 1.03 1.06 0.97 1.09 Receivable days 85.25 79.06 83.41 68.88 79.13 76.95 77.96 63.99 75.19 80.59 Inventory Days 106.28 102.81 117.33 92.96 96.84 96.91 111.14 127.96 172.29 160.79 Payable days 74.10 94.44 36.28 28.05 36.46 33.72 29.57 27.98 45.03 41.52 Cash Conversion Cycle 117.44 87.43 164.47 133.79 139.51 140.15 159.53 163.98 202.45 199.87 Total Debt/Equity 0.45 0.07 0.24 0.21 0.29 0.32 0.39 0.44 0.47 0.36 Interest Cover 22.58 14.88 9.19 17.87 19.88 11.31 7.74 5.41 3.22 5.67

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 305.61 268.38 236.36 208.61 165.32 143.35 119.56 96.86 88.18 79.11 ROA 8.03% 8.70% 9.04% 14.97% 10.10% 11.43% 11.08% 8.06% 6.89% 8.28% ROE 16.00% 16.16% 16.38% 25.59% 17.57% 20.38% 20.56% 15.46% 12.88% 14.28% ROCE 14.02% 17.33% 16.53% 26.64% 20.20% 19.75% 18.98% 16.53% 17.78% 20.10% Fixed Asset Turnover 0.82 0.95 0.83 0.92 0.84 0.96 1.00 1.01 0.93 1.04 Receivable days 81.15 91.49 90.92 66.77 78.70 76.80 77.96 63.83 75.19 80.59 Inventory Days 106.86 107.25 114.27 92.80 97.89 97.55 111.14 127.14 172.29 160.79 Payable days 134.17 174.82 42.10 27.25 33.70 33.48 29.56 28.17 45.39 41.89 Cash Conversion Cycle 53.84 23.92 163.09 132.33 142.89 140.87 159.54 162.80 202.09 199.49 Total Debt/Equity 0.86 0.46 0.60 0.51 0.49 0.54 0.58 0.71 0.64 0.48 Interest Cover 14.06 8.59 6.61 9.57 9.95 9.84 7.67 4.52 3.07 5.41

Top Investors:

kuntal hasmukhlal shah

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hester Biosciences - Quarterly Results
31st Jan 2023, 12:39 PM

Read More
Hester Biosciences acquires technology from ICAR-NIHSAD to develop H9N2 strain vaccine for poultry
28th Dec 2022, 14:28 PM

The agreement has signed for development and commercialization of the Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback